← Evidence map

ArticleJAMA internal medicine2018

Should Metformin Be First-line Therapy for Patients With Type 2 Diabetes and Chronic Kidney Disease?: Informed Patients Should Decide.

Chester B Good et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2018
2019
2020
2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29868705